𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Plasma growth hormone-releasing hormone levels in type 1 (insulin-dependent) diabetic children following a mixed meal

✍ Scribed by Rosskamp, R. ;Haverkamp, F. ;Thomas, B. ;Klumpp, J.


Publisher
Springer-Verlag
Year
1988
Tongue
English
Weight
435 KB
Volume
66
Category
Article
ISSN
1432-1440

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Impaired growth hormone response to huma
✍ N. T. Richards; S. M. Wood; N. D. Christofides; S. C. Bhuttacharji; S. R. Bloom πŸ“‚ Article πŸ“… 1984 πŸ› Springer 🌐 English βš– 570 KB

Human pancreatic growth hormone releasing factor [GRF(1-44)] is the largest molecule of several peptides recently isolated from pancreatic tumours associated with acromegaly. It has been shown to stimulate the release of growth hormone in normal subjects and provides a safe and reliable tool for exa

Serum levels of growth hormone-binding p
✍ G. Massa; L. Dooms; R. Bouillon; M. Vanderschueren-Lodeweyckx πŸ“‚ Article πŸ“… 1993 πŸ› Springer 🌐 English βš– 577 KB

Serum levels of insulin-like growth factor I are reduced in patients with Type 1 (insulin-dependent) diabetes mellitus. To evaluate the role of the hepatic growth hormone receptor in the decreased serum concentrations of insulinlike growth factor I, serum levels of the high affinity growth hormone-b

Dawn phenomenon in Type 1 (insulin-depen
✍ B. BeaufrΓ¨re; M. Beylot; C. Metz; A. Ruitton; R. FranΓ§ois; J. P. Riou; R. Mornex πŸ“‚ Article πŸ“… 1988 πŸ› Springer 🌐 English βš– 580 KB

In order to reassess the role of growth hormone in the dawn phenomenon, we studied eight C-peptide negative diabetic adolescents, who are likely to exhibit important nocturnal growth hormone surges. The insulin infusion rate necessary to maintain euglycaemia was predetermined in each patient from 22

Elevated plasma insulin-like growth fact
✍ S. R. Crosby; C. Tsigos; C. D. Anderton; C. Gordon; R. J. Young; A. White πŸ“‚ Article πŸ“… 1992 πŸ› Springer 🌐 English βš– 635 KB

Previous studies have suggested that nerve regeneration may be defective in patients with diabetic polyneuropathy. Since insulin-like growth factor I (IGF-I) has been shown to stimulate nerve regeneration, and IGF binding protein-1 is acutely regulated by plasma insulin we have investigated the rela